STSA
Satsuma Pharmaceuticals, Inc. Common Stock
STSA
STSA
Delisted
STSA was delisted on the 7th of June, 2023.
48 hedge funds and large institutions have $49.5M invested in Satsuma Pharmaceuticals, Inc. Common Stock in 2020 Q4 according to their latest regulatory filings, with 12 funds opening new positions, 13 increasing their positions, 15 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
48
Holders Change
+2
Holders Change %
+4.35%
% of All Funds
0.85%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
12
Increased
13
Reduced
15
Closed
10
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
Morgan Stanley
New York
|
$4.58M |
2 |
![]()
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
$902K |
3 |
![]()
JPMorgan Chase & Co
New York
|
$429K |
4 |
Russell Investments Group
London,
United Kingdom
|
$359K |
5 |
PP
PDT Partners
New York
|
$309K |